Product Images Pemetrexed
View Photos of Packaging, Labels & Appearance
- Figure 1 - pem hansoh ns fig1
- Figure 2 - pem hansoh ns fig2
- Figure 3 - pem hansoh ns fig3
- Figure 4 - pem hansoh ns fig4
- Figure 5 - pem hansoh ns fig5
- Figure 6 - pem hansoh ns fig6
- Figure 7 - pem hansoh ns fig7
- Figure 8 - pem hansoh ns fig8
- Figure 9 - pem hansoh ns fig9
- Structural Formula - pem hansoh ns struct
- PRINCIPAL DISPLAY PANEL – Pemetrexed for Injection, USP Northstar 100 mg Carton - peme hansoh 100mg ns carton
- PRINCIPAL DISPLAY PANEL – Pemetrexed for Injection, USP 100 mg Northstar Vial Label - peme hansoh 100mg ns cont
- PRINCIPAL DISPLAY PANEL – Pemetrexed for Injection, USP Northstar 500 mg Carton - peme hansoh 500mg ns carton
- PRINCIPAL DISPLAY PANEL – Pemetrexed for Injection, USP Northstar 500 mg Vial Label - peme hansoh 500mg ns cont
Product Label Images
The following 14 images provide visual information about the product associated with Pemetrexed NDC 72603-325 by Northstar Rxllc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - pem hansoh ns fig1
Figure 2 - pem hansoh ns fig2
Figure 3 - pem hansoh ns fig3
Figure 4 - pem hansoh ns fig4
Not available.*
Figure 5 - pem hansoh ns fig5
This is a data table showing survival probability and the number of patients at risk for each treatment group (pematesed and placebo). It also displays the survival time in months for the patients involved in the study.*
Figure 6 - pem hansoh ns fig6
This is a table showing survival probability over time for patients treated with a drug (B i @ e 9 W g sar . a0 @y W%) compared to those who received a placebo. The table includes the number of patients at risk for each time point, starting from the initial cohort size and decreasing as time progresses. This data can be used to analyze the effectiveness of the drug in terms of survival rates over a certain period.*
Figure 7 - pem hansoh ns fig7
This text provides data on survival probability and the number of patients at risk over time for two groups: pemeexed and Placebo. The survival time in months is also displayed. The group pemeexed has more patients at risk compared to the Placebo group at different time intervals.*
Figure 8 - pem hansoh ns fig8
This is a table showing the survival probability and survival time in months for two groups of patients: Pemexsd and Placebo. The data includes the number of patients at risk for each timepoint.*
Figure 9 - pem hansoh ns fig9
Structural Formula - pem hansoh ns struct
PRINCIPAL DISPLAY PANEL – Pemetrexed for Injection, USP Northstar 100 mg Carton - peme hansoh 100mg ns carton
PRINCIPAL DISPLAY PANEL – Pemetrexed for Injection, USP 100 mg Northstar Vial Label - peme hansoh 100mg ns cont
PRINCIPAL DISPLAY PANEL – Pemetrexed for Injection, USP Northstar 500 mg Carton - peme hansoh 500mg ns carton
This text appears to be a pharmaceutical label for Pemetrexed for Injection USP, contained in a single-dose vial for intravenous use only. It provides information on the composition, reconstitution, dosage, administration, storage instructions, caution regarding its use as a cytotoxic agent, and manufacturing details including a contact address. It is essential for healthcare professionals to refer to this label for proper handling and administration of the medication.*
PRINCIPAL DISPLAY PANEL – Pemetrexed for Injection, USP Northstar 500 mg Vial Label - peme hansoh 500mg ns cont
This is a product description for "Pemetrexed for Injection", intended for intravenous use as a cytotoxic agent. The product is a single dose vial with NDC72603-425-01.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
